Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02065895 · ClinicalTrials.gov registry record · NA
Effect of Gain on Closed-Loop Insulin
A NA study, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02065895 is a NA study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 8 participants.
The verdict
NCT02065895, a NA study, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to test the ability of an advanced external Physiologic Insulin Delivery (ePID) algorithm (a step by step process used to develop a solution to a problem) to get acceptable meal responses over a range of gain. Gain is defined as how much insulin is given in response to a change in a patient's glucose level. This study also examines the effectiveness of the external Physiologic Insulin Delivery (ePID) closed-loop insulin delivery computer software. The investigators would like to assess whether fasting target levels can be achieved as the closed-loop gain increases or decreases, and to evaluate the system's ability to produce an acceptable breakfast meal response.
Interventions
- DEVICE HIGH error
- DEVICE NO error
- DEVICE LOW error
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02065895
The ClinicalTrials.gov registry entry for NCT02065895 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which HIGH error is the first listed.
NCT02065895 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02065895 about?
NCT02065895 is a clinical study titled "Effect of Gain on Closed-Loop Insulin". The purpose of this study is to test the ability of an advanced external Physiologic Insulin Delivery (ePID) algorithm (a step by step process used to develop a solution to a problem) to get acceptable meal responses over a range of gain. Gain is defined as how much insulin is given in response to a...
What is the current status of trial NCT02065895?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2013-12. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02065895?
The interventions under investigation include: HIGH error (DEVICE), NO error (DEVICE), LOW error (DEVICE).
Who is sponsoring clinical trial NCT02065895?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.